Piramal Pharma
PPLPHARMA.NS
#3055
Rank
HK$31.95 B
Marketcap
HK$24.21
Share price
1.57%
Change (1 day)
104.18%
Change (1 year)

Revenue for Piramal Pharma (PPLPHARMA.NS)

Revenue in 2024 (TTM): HK$8.08 Billion

According to Piramal Pharma's latest financial reports the company's current revenue (TTM ) is HK$8.04 Billion. In 2023 the company made a revenue of HK$7.30 Billion an increase over the revenue in the year 2022 that were of HK$3.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Piramal Pharma from 2022 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$8.08 B10.59%
2023 HK$7.30 B125.34%
2022 HK$3.24 B